WallStreetZenWallStreetZen

NASDAQ: BJDX
Bluejay Diagnostics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their BJDX stock forecasts and price targets.

Forecast return on equity

Is BJDX forecast to generate an efficient return?

Company
-14.53%
Industry
16.04%
Market
328.93%
BJDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BJDX forecast to generate an efficient return on assets?

Company
-10.97%
Industry
10.03%
BJDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BJDX earnings per share forecast

What is BJDX's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.33
Avg 2 year Forecast
-$0.30

BJDX revenue forecast

What is BJDX's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$5.2M
Avg 2 year Forecast
$8.0M

BJDX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
BJDX$1.10N/AN/A
IVF$1.38N/AN/A
AEMD$3.72$15.00+303.23%Hold
VERO$1.85N/AN/A
BBLG$2.10N/AN/A
View Top Medical Device Stocks

Bluejay Diagnostics Stock Forecast FAQ

What is BJDX's earnings growth forecast for 2025-2026?

(NASDAQ: BJDX) Bluejay Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 27.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,897.81%.

Bluejay Diagnostics's earnings in 2025 is -$20,073,714.On average, 4 Wall Street analysts forecast BJDX's earnings for 2025 to be -$592,133, with the lowest BJDX earnings forecast at -$568,912, and the highest BJDX earnings forecast at -$609,549.

In 2026, BJDX is forecast to generate -$536,621 in earnings, with the lowest earnings forecast at -$515,577 and the highest earnings forecast at -$552,403.

If you're new to stock investing, here's how to buy Bluejay Diagnostics stock.

What is BJDX's revenue growth forecast for 2025-2026?

(NASDAQ: BJDX) Bluejay Diagnostics's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 4.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,457.73%.

Bluejay Diagnostics's revenue in 2025 is $0.On average, 3 Wall Street analysts forecast BJDX's revenue for 2025 to be $9,351,856, with the lowest BJDX revenue forecast at $8,985,401, and the highest BJDX revenue forecast at $9,627,604.

In 2026, BJDX is forecast to generate $14,547,533 in revenue, with the lowest revenue forecast at $13,977,895 and the highest revenue forecast at $14,975,668.

What is BJDX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: BJDX) forecast ROA is -10.97%, which is lower than the forecast US Medical Devices industry average of 10.03%.

What is BJDX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: BJDX) Bluejay Diagnostics's current Earnings Per Share (EPS) is -$28.98. On average, analysts forecast that BJDX's EPS will be -$0.33 for 2025, with the lowest EPS forecast at -$0.31, and the highest EPS forecast at -$0.34. In 2026, BJDX's EPS is forecast to hit -$0.30 (min: -$0.28, max: -$0.30).

What is BJDX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: BJDX) forecast ROE is -14.53%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.